Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2001;88:456-457

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabelink, T. J.
Right arrow Articles by Stroes, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabelink, T. J.
Right arrow Articles by Stroes, E.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow Risk Factors
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2001;88:456.)
© 2001 American Heart Association, Inc.


Editorial

Atherosclerosis

Defeat of the Defense?

Ton J. Rabelink, Erik Stroes

From the Department of Vascular Medicine, University Hospital (T.J.R.), Utrecht, and Department of Vascular Medicine, Academic Medical Hospital (E.S.), Amsterdam, The Netherlands.

Correspondence to Ton J. Rabelink, Professor of Medicine, University Medical Center Utrecht, Room F02.126, PO Box 85500 3508 GA, Utrecht, The Netherlands. E-mail T.Rabelink@worldonline.nl


Key Words: heme oxygenase • atherosclerosis • oxidative stress


*    Introduction
 
Heme oxygenases (HOs) are rate-limiting enzymes that catalyze the conversion of heme into equimolar amounts of biliverdin, carbon monoxide (CO), and iron.1 Biliverdin is subsequently reduced to bilirubin pigment by biliverdin reductase.2 The heme oxygenases consist of 2 major isoforms, HO-1 and HO-2. Whereas HO-2 is constitutively produced within the brain, testes, and the endothelium, HO-1 gene expression is inducible by heme, cytokines, nitric oxide (NO) donors,3 4 5 and agents and conditions associated with increased oxidant stress, eg, oxidized LDL and ischemia/reperfusion injury.6 7 HO-1 induction has been shown to have potent antioxidant effects.8 Indeed, HO-1 knockout mice are more sensitive toward oxidant insults,9 10 whereas HO-1 is upregulated in models associated with increased oxidative stress, such as sepsis, organ transplantation, and atherosclerosis.11 12 Increased sensitivity to oxidant injury was also one of the hallmarks of a recently described patient with HO-1 deficiency.13 The potential importance of HO-1 as an antioxidant system in humans is underscored by the observation that a microsatellite polymorphism in the promotor region of the HO-1 gene could be linked to the decreased inducibility of HO-1 and associated with the development of emphysema in smokers.14

The antioxidant effect of HO-1 can be explained by several mechanisms. First, HO-1 degrades the intracellular pro-oxidant heme.15 In addition, the resulting reaction product, bilirubin, can act as a potent peroxyl radical scavenger.16 In this respect, the reduction of leukocyte adhesion during oxidative stress by HO-1 induction could largely be attributed to the antioxidant effects of bilirubin.17 HO-1 also results in the generation of CO, . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
HypertensionHome page
B. Braam, R. de Roos, H. Bluyssen, P. Kemmeren, F. Holstege, J. A. Joles, and H. Koomans
Nitric Oxide-Dependent and Nitric Oxide-Independent Transcriptional Responses to High Shear Stress in Endothelial Cells
Hypertension, April 1, 2005; 45(4): 672 - 680.
[Abstract] [Full Text] [PDF]